PRELUDE CAPITAL MANAGEMENT, LLC - PREFORMED LINE PRODS CO ownership

PREFORMED LINE PRODS CO's ticker is PLPC and the CUSIP is 740444104. A total of 67 filers reported holding PREFORMED LINE PRODS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PREFORMED LINE PRODS CO
ValueSharesWeighting
Q2 2020$7,0000.0%1440.0%0.00%
Q1 2020$7,000
-78.8%
144
-73.7%
0.00%
-100.0%
Q4 2019$33,000
+6.5%
548
-4.4%
0.00%0.0%
Q3 2019$31,000
-66.7%
573
-65.7%
0.00%
-80.0%
Q2 2019$93,000
-45.9%
1,672
-48.4%
0.01%
-50.0%
Q1 2019$172,000
+21.1%
3,241
+23.5%
0.01%0.0%
Q4 2018$142,000
+246.3%
2,625
+348.0%
0.01%
+400.0%
Q3 2018$41,000
+17.1%
586
+50.3%
0.00%0.0%
Q2 2018$35,000
+25.0%
390
-10.3%
0.00%0.0%
Q1 2018$28,000
-24.3%
435
-21.1%
0.00%
-33.3%
Q3 2017$37,000
-48.6%
551
-55.8%
0.00%
-66.7%
Q4 2016$72,000
+188.0%
1,246
+107.7%
0.01%
+200.0%
Q3 2016$25,000
-37.5%
600
-40.0%
0.00%
-50.0%
Q2 2016$40,000
-42.0%
1,000
-47.2%
0.01%
-40.0%
Q1 2016$69,000
-13.8%
1,893
-0.4%
0.01%
-16.7%
Q4 2015$80,000
-17.5%
1,900
-26.9%
0.01%
-14.3%
Q3 2015$97,000
+3.2%
2,600
+4.0%
0.01%
+7.7%
Q2 2015$94,000
+17.5%
2,500
+31.6%
0.01%
+18.2%
Q1 2015$80,000
-26.6%
1,900
-5.0%
0.01%
-31.2%
Q4 2014$109,000
+73.0%
2,000
+66.7%
0.02%
+77.8%
Q3 2014$63,000
-3.1%
1,2000.0%0.01%0.0%
Q2 2014$65,000
+4.8%
1,200
+33.3%
0.01%
+12.5%
Q1 2014$62,0009000.01%
Other shareholders
PREFORMED LINE PRODS CO shareholders Q4 2017
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 31,122$2,309,0001.84%
Dean Capital Management 9,558$709,0000.65%
Walthausen & Co., LLC 71,690$5,132,0000.55%
CM Management, LLC 8,000$594,0000.43%
Invenomic Capital Management LP 19,671$1,459,0000.35%
DEAN INVESTMENT ASSOCIATES, LLC 14,587$1,082,0000.20%
Robotti & Company 10,000$742,0000.19%
SHAKER INVESTMENTS LLC/OH 5,277$392,0000.18%
KEYBANK NATIONAL ASSOCIATION/OH 402,652$29,877,0000.13%
WealthBridge Capital Management, LLC 4,700$349,0000.13%
View complete list of PREFORMED LINE PRODS CO shareholders